BackSumitomo Pharma , Ltd. Overview
Sumitomo Pharma Co., Ltd.

Sumitomo Pharma , Ltd. P/E Ratio

Valuation check: SMDPY's P/E ratio is 17.24, below the sector sector average of 22.73.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

17.24

P/E Ratio

17.24

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Sumitomo Pharma , Ltd. (SMDPY) FAQ

As of the most recent data, SMDPY shows a P/E ratio of 17.24. That is below the sector sector average of 22.73. Scroll down for historical charts and peer comparison views.

The its sector sector average P/E ratio is about 22.73. Sumitomo Pharma , Ltd. is at 17.24, which is lower that average. That is roughly 24.2% below the sector mean. Use the comparison chart on this page to see how SMDPY stacks up against individual peers as well.

Investors watch SMDPY's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Sumitomo Pharma , Ltd.'s latest reading is 17.24. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Sumitomo Pharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 17.24) with ownership activity and broader fundamentals.